Collegium Pharmaceutical Inc.
COLL | NASDAQ
$23.21
+$0.17 (+0.74%)
Sep 22, 2026, 11:22 AM ET · Market open
Market Data
Market Cap $747.27M
Enterprise Value $1.48B
Beta 0.72
Average Volume 554.1K
Shares Outstanding (Diluted) 32.46M
Shares Change YoY -16.93%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US19459J1043
Price Performance
Price Change 1M -15.0%
Price Change 3M -33.5%
Price Change 6M -30.7%
Price Change YTD -49.4%
Price Change 1Y -35.4%
Price Change 3Y 3.5%
Price Change 5Y 12.7%
1M CAGR (ann.) -21.8%
1Y CAGR (ann.) -36.3%
5Y CAGR (ann.) 2.8%
All-Time CAGR 5.7%
Valuation
PE Ratio 18.58
Forward PE 3.02
PEG Ratio 0.51
Forward PEG -1.47
PS Ratio 0.92
Forward PS 0.90
PB Ratio 2.40
P/FCF Ratio 1.94
P/Adj. FCF Ratio 2.27
P/OCF Ratio 2.27
EV/Sales 1.83
EV/EBIT 6.16
EV/EBITDA 2.52
EV/FCF 3.83
Earnings Yield 5.4%
FCF Yield 51.5%
Adj. FCF Yield 44.1%
Financial Health
Net Debt $723.36M
Total Debt $857.79M
Cash & Short-Term Investments $129.47M
Total Assets $2.14B
Current Ratio 1.03
Quick Ratio 0.84
Debt / Equity Ratio 2.75
Debt / EBITDA 1.46
Debt / FCF 2.23
OCF / Debt 0.45
Interest Coverage 0.98
Altman Z-Score 0.94
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 60.0%
Operating Profit Margin 19.6%
EBITDA Margin 72.6%
Net Profit Margin 5.9%
FCF Margin 47.6%
Adj. FCF Margin 40.8%
SBC / Revenue 5.6%
SBC Impact (per share) -14.5%
Returns
Return on Assets 2.2%
Return on Equity 16.0%
Return on Invested Capital 6.1%
Return on Capital Employed 10.3%
Return on Tangible Assets 6.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 14.6%
Revenue CAGR 5Y 19.9%
Revenue CAGR 10Y 19.8%
EPS CAGR 3Y -41.4%
EPS CAGR 5Y -14.5%
EPS CAGR 10Y 3684.5%
FCF CAGR 3Y 17.9%
FCF CAGR 5Y 30.5%
FCF CAGR 10Y 30.6%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 78.4%
Revenue Growth Next 3Y 3.8%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $1.80
EPS Growth Est (next Q) -20.0%
Revenue Est (next Q) $217.97M
Revenue Growth Est (next Q) 4.1%
Fair Value Estimates
Graham Number $16.37
Graham Upside -28.9%
Lynch Fair Value $6.20
Lynch Upside -73.1%
Price Target $47.33
Price Target Upside 105.4%
Cash Flow
Operating Cash Flow $387.04M
Free Cash Flow $385.12M
Adj. Free Cash Flow $329.31M
FCF Per Share $10.11
OCF Per Share $10.16
OCF/S Ratio 40.8%
Income Statement
Revenue $808.21M
Gross Profit $485.09M
Operating Income $158.51M
EBITDA $586.57M
Net Income $47.92M
EPS (Diluted) $1.24
Revenue / Employee $1.91M
Profit / Employee $113.27K
Employees 423
Add to Watchlist
Select watchlists to add or remove COLL